Market Overview

Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2018 Financial Results on August 7, 2018


Eagle Pharmaceuticals, Inc. ("Eagle" or "the Company") (NASDAQ:EGRX)
today announced that the Company will release its 2018 second quarter
financial results on Tuesday, August 7, 2018, before the market opens.

Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial
Officer, will host a conference call to discuss the results as follows:

Date Tuesday, August 7, 2018
Time 8:30 a.m. EDT
Toll free (U.S.) 877-876-9177
International 785-424-1669
Webcast (live and replay),
under the "Investor Relations" section


A replay of the conference call will be available for one week after the
call's completion by dialing 800-727-5306 (US) or 402-220-2670
(International) and entering conference call ID EGRXQ218. The webcast
will be archived for 30 days at the aforementioned URL.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and
commercializing injectable products that address the shortcomings, as
identified by physicians, pharmacists and other stakeholders, of
existing commercially successful injectable products. Eagle's strategy
is to utilize the FDA's 505(b)(2) regulatory pathway. Additional
information is available on the company's website at

View Comments and Join the Discussion!